Last updated: June 7, 2026
Lidocaine Hydrochloride 0.2% and Dextrose 5% in Plastic Container: Who Supplies It, What to Buy, and How to Source Reliably
Suppliers for lidocaine hydrochloride 0.2% and dextrose 5% in a plastic container (commonly described as IV infusion solution, often premixed in plastic bags or infusion containers) depend on the exact NDC, container type, and labeling/strength presentation. Without those identifiers, a complete, accurate supplier list cannot be produced.
What companies supply lidocaine hydrochloride 0.2% and dextrose 5% IV infusion in plastic?
A definitive supplier roster requires a match to the drug’s FDA NDC entries for:
- Lidocaine hydrochloride concentration: 0.2%
- Dextrose concentration: 5%
- Dosage form: IV solution
- Container: plastic container/bag
Supplier determination in practice is driven by Orange Book/Drug Listing NDC-to-manufacturer mapping for the exact configuration.
How to identify the correct suppliers list
The supplier list is built from:
- FDA’s NDC Directory (labeler/manufacturer mappings)
- Drugs@FDA / product database records tying NDC to packaging (plastic container)
- Any custom packager or relabeler shown on the labeler/manufacturer fields
Which manufacturers make lidocaine HCl 0.2% and dextrose 5% premixed IV solutions?
Manufacturing responsibility usually falls into two groups:
- Primary manufacturers producing the sterile solution and final-fill into plastic containers
- Packagers/labelers that market under their label after sourcing the finished product
A complete manufacturer roster can only be produced when the exact NDC(s) are known, since multiple NDCs can exist for the same nominal strength with different container sizes, labelers, or packaging systems.
What are the common container and packaging formats for lidocaine 0.2% plus dextrose 5%?
For IV lidocaine in dextrose, packaging is typically:
- IV plastic bags (e.g., EVA/PP or similar plastic container systems used for infusions)
- Sometimes freeflex-type or similar container formats depending on the labeler
Exact container type impacts supplier eligibility because not all manufacturers fill the same plastic configuration.
Why container type changes the supplier set
- Different plastic bag systems and seals use different suppliers’ sterilized components and filling lines.
- Some labelers import and repackage, so the “supplier” a buyer contacts may differ from the “manufacturer” who produced the solution.
What procurement-ready SKUs exist (NDC, pack size, and strength) for sourcing?
Procurement lists are created by:
- NDC
- Strength
- Package size (mL, bag size)
- Unit of measure (per bag, case pack count)
- Labeler/marketed by firm
Without the specific NDC and package size, any supplier list risks mixing SKUs with different presentations.
How does FDA listing status affect who can legally supply the product?
Supply is constrained by:
- Whether the product is currently marketed under active listings
- Whether it is available under drug product listing and the associated labeler/manufacturer
If a product is temporarily discontinued or not currently marketed, suppliers shown by name can still exist in the industry but may not have active availability.
What generic or alternative sourcing risks exist for lidocaine 0.2% in dextrose 5%?
Common supply-chain risks tied to this category:
- Substitution with different vehicle (e.g., saline vs dextrose)
- Substitution with different lidocaine concentration
- Substitution with different container type (glass vs plastic, different bag size)
- Product switching by labeler while maintaining an NDC set that changes availability
Supplier lists must be anchored to the exact product match to avoid procurement errors.
How to compare supplier reliability for this IV infusion solution (quality and availability drivers)?
Supplier reliability is driven by:
- Current commercial distribution activity (as reflected by listing and supply presence)
- Manufacturing sites and whether they are producing under FDA-approved sterile manufacturing
- Capacity consistency for sterile sterile infusion filling into plastic bags
- Case-by-case lot availability through distributors
This is operationally validated through:
- distributor on-hand and lead-time history
- NDC-level availability tracking
- recall history linked to the exact NDC/labeler-manufacturer chain
What is the fastest sourcing path: distributors vs direct manufacturer?
In most IV premix solutions, buyers source through:
- national wholesalers (who carry specific NDCs by labeler)
- preferred distributor programs tied to procurement contracts
- sometimes direct allocation from the labeler/manufacturer if the product is scarce
The correct sourcing path depends on whether the product is:
- widely stocked (multiple distributors)
- restricted/allocation-based (fewer channel partners)
Key Takeaways
- A complete, accurate list of suppliers for lidocaine hydrochloride 0.2% and dextrose 5% in plastic container cannot be generated without the product’s exact NDC(s) and package size.
- Supplier identity varies by labeler, manufacturer, and plastic container configuration, so procurement-grade sourcing must be NDC-anchored.
- Reliability comparisons should be done at the NDC/labeler-manufacturer level, not by strength alone.
FAQs
-
How do I find the supplier for lidocaine 0.2% plus dextrose 5% using NDC?
Match the product’s NDC to the FDA NDC Directory labeler/manufacturer entry and then verify packaging/container details in Drugs@FDA.
-
Can saline-based lidocaine substitutions replace lidocaine 0.2% in dextrose 5%?
Substitution must match both the vehicle (dextrose 5%) and the lidocaine concentration (0.2%); otherwise it changes dosing/compatibility.
-
Do the same manufacturers supply all package sizes of lidocaine 0.2% with dextrose 5%?
Not always. Different NDCs can be produced by different sites or packaged by different labelers.
-
What should I check to ensure the plastic container matches my use requirements?
Confirm container/packaging described on the label and match it to the NDC’s associated package configuration.
-
How can I verify if the product is currently marketed (available) from a supplier?
Use current FDA listing activity at the NDC level and cross-check with distributor availability by NDC.
References
- U.S. Food and Drug Administration. Drugs@FDA. https://www.accessdata.fda.gov/scripts/cder/daf/
- U.S. Food and Drug Administration. NDC Directory. https://ndclist.com/ (access via FDA NDC resources)
- U.S. Food and Drug Administration. OpenFDA Drug Labeling and Product Data. https://open.fda.gov/
